The prevalence of HIV/hepatitis C virus (HCV) coinfection in Spain is one of the highest since both these infections share routes of transmission. Resolution of HCV in coinfected patients depends on HCV genotype and treatment. The recommended treatment consisted of subcutaneous administration of pegylated interferon and oral ribavirin. Treatment is administered for a specific period (from 6 months to 1 year), but has secondary effects that limit the patient's daily life and require a health education process. The PRECEDE method can be used to make individual and group behavioral diagnoses that aim to effect changes in patients' behavior, attitudes and knowledge. An accurate preintervention behavioral diagnosis guarantees the suitability and effectiveness of interventions to support HIV/HCV coinfected individuals in treatment adherence.
|Translated title of the contribution||Health education project in self-administration of pegylated interferon in HIV/hepatitis C virus coinfection using the PRECEDE method as a tool for behavioral diagnosis|
|Number of pages||6|
|Publication status||Published - 1 Jan 2006|